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ABSTRACT 
 
 
 
Preliminary Results for TAT-Mediated Photoactivatable Cell Delivery. (April 2011) 
 
Matthew Ellis Grunewald 
Department of Biochemistry and Biophysics 
Texas A&M University 
 
Research Advisor: Dr. Jean-Philippe Pellois 
Department of Biochemistry and Biophysics 
 
Protein delivery into cells is often achieved through use of cell-penetrating peptides 
(CPPs).  TAT (an HIV peptide) is one of the most efficient CPPs and, when incubated 
with cells, induces macropinocytosis of the surrounding medium.  This brings 
coincubated extracellular cargo into endosomes, where they often remain trapped 
without outside stimulus.  We hypothesized that TMR conjugated to TAT could induce 
medium uptake and, when photoactivated by light treatment, cause endosomal release of 
cargo.  We performed several experiments using TMR-TAT and eGFP cargo at various 
conditions, but initial trials show no detectable delivery.  Though our results are only 
preliminary, we have observed several phenomena that inhibit delivery and/or detection 
of delivery, including low endosomal uptake and release, fluorescent CPP adherence to 
the dish surface, and high cell death and buildup of cellular debris.  In future trials, we 
plan to correct these issues by modifying reagent concentrations, using different 
reagents, and changing intensity of light treatment.  In summary, we believe delivery is 
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still possible after changing various parameters.  If future trials are successful, TMR-
TAT and cargo coincubation may prove to be an efficient method to deliver therapeutic 
proteins and has implications in patient drug treatment and in vitro cell modulation. 
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NOMENCLATURE	  
 
Cargo The biomolecule to be delivered into the cell 
CPP Cell-penetrating peptide, facilitates cargo internalization 
into cells, e.g. TAT  
 
Crocetin Singlet oxygen scavenger, inhibits TMR-mediated 
endosomal release 
 
eGFP Enhanced green fluorescent protein, used as cargo 
FITC A green fluorophore, used as cargo or as photosensitizer 
HA2 Influenza hemagglutinin, induces membrane leakage at 
low pH 
 
PCI Photochemical internalization, light-mediated delivery 
PDT Photodynamic therapy, method of photoinduced cell death 
Photosensitizer Photoexcitable chemical used to kill cells in PDT 
PTD Protein transduction domain, CPP part of a protein 
ROI Reactive oxygen species 
Singlet oxygen Unstable ROS, responsible for death in PDT 
SYTOX Blue Nuclear stain to detect cell death 
TAT HIV transactivator of transcription, CPP used in our 
studies 
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CHAPTER I 
INTRODUCTION 
 
Rationale 
In general, delivery of exogenous or foreign compounds into cells or tissues is difficult.  
Oral ingestion and direct injection are historically the most common methods of drug 
delivery due to simplicity of administration.  Unfortunately, these routes of delivery 
allow only a slim margin of possible drugs that balance properties need for effective 
transfer, including lipophilicity, lack of polarity, metabolic stability (1).  Clearly new 
methods to deliver polar and hydrophilic biomolecules, such as proteins, needs to be 
pursued.  Currently, one of the most studied forms of delivery is transduction of 
extracellular biomolecules across the plasma membrane into the cell.  
 
Once a competent and reliable method of direct molecule transduction is developed, it 
will have applications in many biological and chemical areas.  For instance, fluorescent 
markers (e.g. eGFP and derivatives, quantum dots, etc.) and metabolic markers could be 
transduced into culture or tissue cells to study localization and duration of biochemical 
processes in real time (2).  Antibodies could be used for intracellular purposes, including 
neutralization of viral proteins, diagnosis of disorders, and specific biomolecule imaging 
_______________ 
This thesis follows the style of The Journal Biological Chemistry. 
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(3).  Protein/peptide-based therapeutic drugs, especially anticancer molecules, could be 
delivered directly to site of damage (4).  Transcription factors and growth/differentiation 
factors could be applied in vitro or in vivo to direct cell fate or even induce pluripotency 
(5).  Finally, nonprotein molecules such as MRI contrast agents and nucleic acids could 
be used to enhance magnetic imaging resolution and direct gene expression respectively 
(6).   
 
Cell-penetrating peptides 
The lipid bilayer membrane of eukaryotic cells has evolved into a tightly regulated 
barrier that controls biomolecule translocation.  This membrane system has adapted well 
to keep unnecessary and possibly harmful components out of the cell.  This poses a 
significant barrier to delivery of exogenous chemicals, especially proteins and other 
macromolecules.  Mechanical and electrical methods to bypass this barrier often risk 
compromising membrane integrity and/or are very technical and time consuming (7).  
Transduction methods that exploit intrinsic biological processes have been proposed and 
studied, though most are inefficient and show inconsistent results.  Several studies have 
shown the importance of cell-penetrating peptides (CPPs), which can be utilized in 
conjugation with the cargo molecule to effect delivery into a cell. 
 
CPPs are a group of peptides that enhance cellular uptake of surrounding molecules by 
various means.  In general, CPPs are usually short peptide sequences with several 
positively charged residues (usually lysine or arginine).  A CPP could be isolated from 
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an organism, usually as a protein domain (or protein transduction domain/PTD), or be a 
synthetic construct, often to mimic a known PTD.  Common PTDs include the TAT 
domain (from the HIV transactivator of transcription) and penetratin (the third α helix of 
Drosophila antennapedia homeodomain), and synthetic CPPs include R9 (arginine 
nonamer) and transportan (a chimeric peptide) (6).   
 
TAT as a mediator of delivery 
The TAT domain, simplified to TAT, is one of the most studied CPPs to date.  The 
peptide is found naturally as a PTD of the TAT protein of HIV, which activates 
transcription of viral genes in the host cell nucleus.  In 1988, Frankel et al. observed 
spontaneous cellular uptake of TAT protein (8).  This ability to induce internalization is 
conserved in a small region (~10 amino acids, sequence: GRKKRRQRRRG) of the 
protein (9), which is typically the only region used for experimental transductions. 
 
The mechanisms behind TAT-induced transduction are not fully understood but seem to 
be complex and involve several different methods of internalization.  TAT directly 
crosses the plasma membrane into the cytosol at extracellular concentrations above a 
threshold (~10 µM) (10).  Below this threshold, endocytic internalization pathways 
predominate, especially macropinocytosis (mass uptake of surrounding medium) (11).  
This uptake seems to be dependent on cell matrix heparin sulfate proteoglycans (12), and 
positively-charged TAT binds directly to the negatively-charged heparin sulfate 
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moieties, mediated by ionic interactions (13).  After transduction, TAT localizes to the 
nucleoli of the cell nucleus (14). 
 
Several methods have been studied to exploit TAT-mediated internalization for delivery 
of cargo molecules into cells.  The simplest method is incubation of cells in medium 
containing TAT conjugated directly to the cargo of interest.  But after the TAT-cargo is 
taken up by the cell, it often remains trapped in the endosomes and is eventually 
degraded by lysosomal fusion.  A regulatable method to induce endosomal lysis must be 
introduced to release the cargo into the cytosol before it is degraded.  For instance, the 
influenza hemagglutinin protein HA2 can be ligated to the TAT-cargo complex.  HA2 
promotes membrane fusion and leakage at low pH levels, initiating release of endosomal 
contents after slight acidification from endosomal maturation/lysosomal fusion (15).  
This improves delivery significantly but requires modification of the cargo, possibly 
altering its function or final destination (TAT localizes to the nucleoli.).  Recently we 
showed that TAT conjugated to E5 (a HA2 derivative) coincubated with unmodified 
cargo is sufficient to induce endocytosis and cargo release into the cytosol (16).  But this 
method still shows relatively low rates of delivery and is regulated by the pH of the 
endosomes—it cannot be manually controlled. 
 
Photoacceleration of delivery 
In recent decades, significant progress has been made in initiation/regulation of 
biochemical reactions by light treatment.  Of note is the cytotoxic treatment called 
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photodynamic therapy, or PDT.  PDT involves directly or intravenously treating cells, 
usually cancerous, with a photosensitizer, which is general inert in the absence of light 
treatment.  Damaged or cancerous tissue is then irradiated by light of a specific 
wavelength, activating the photosensitizer.  (An ideal photosensitizer is also selectively 
favored for absorption by cancerous cells.)  Photoactivation initiates several biochemical 
reactions that interrupt cellular processes, killing the irradiated cells (17). 
 
The mechanisms behind photoactivated cell death are complex and not fully understood.  
In general, photosensitizers are easily photoexcited to a higher electronic state.  Energy 
from this excited state is transferred via several routes, including radiative (fluorescence) 
and nonradiative (heat) decay or direct electron transfer.  This can lead to production of 
reactive oxygen species (ROS) by several different routes.  For example, an excited 
photosensitizer can directly transfer an electron to O2, eventually leading to formation of 
H2O2 (18).  H2O2 can then diffuse throughout the cell and split into reactive hydroxyl 
radicals, which can react with nearly any biomolecule (19).  Most PDT protocols use a 
chemical with high singlet oxygen (1O2) production capability, such as porphyrin-like 
molecules (20).  Singlet oxygen is a ROS with a highly unstable spin state configuration 
that is formed from direct energy transfer from the excited photosensitizer (21).  Due to 
its instability, singlet oxygen possesses a very short lifetime, and its area of reactivity is 
limited to the immediate area around the photosensitizer (18).  Even so, 1O2 formation is 
one of the primary mechanisms driving PDT-induced cell process disruption and death. 
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We recently showed that induction of cell death was possible via singlet oxygen 
production by photosensitized TMR (tetramethylrhodamine), even this fluorophore 
possesses low 1O2 production ability.  TMR by itself is incapable of membrane lysis and 
is nontoxic to cells, even in the presence of significant light.  However, when conjugated 
to TAT, TMR-TAT is lethal during photosensitization after incubation (22).  We 
proposed the following model:  TMR-TAT is internalized into endosomes, and 
membrane-associated TAT localizes TMR to inner face of the endosome.  Light 
treatment electronically excites TMR, causing singlet oxygen production and endosomal 
leakage.  TMR-TAT then escapes into the cytosol, allowing disruption of the plasma 
membrane and cell death (22). 
 
The PDT protocol can be modified to deliver biomolecules, allowing manual temporal 
and spatial control.  This method is called photochemical internalization (PCI) and uses 
light as a mediator of endosomal cargo release.  In order to prevent cell death seen in 
PDT, PCI utilizes less reactive photosensitizers such as TMR or fluorescein (FITC) in 
conjunction with a CPP such as TAT.  Matsushita et al. showed light treatment induces 
endosomal release and cytosolic delivery of 11R-p53 (polyarginine CPP ligated to p53, 
an anticancer protein) conjugated to the fluorophore FITC after internalization (23).  
Finally, Gillmeister et al. showed that TMR-labeled TAT-GFP can be delivered by 
similar internalization and light treatment (24).  But both these experiments require 
modification of the cargo (p53 or GFP), possibly altering cargo function or 
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localization.  Furthermore, the reactive photosensitizer is conjugated directly to the 
cargo, which could result in chemical alterations. 
 
Our method 
In the experiments presented here, we tested a novel method of photochemical 
internalization mediated by TMR-TAT.  We coincubated HeLa cells with TMR-TAT 
and unmodified eGFP to induce cellular uptake of both.  We then visualized the resulting 
localization patterns of both fluorophores and attempted to photoaccelerate TMR-TAT-
mediated endosomal release by light treatment at various intensities.  Presumably, we 
can prevent continued membrane lysis by varying light treatment parameters. 
 
Furthermore, we hypothesized that cytotoxicity associated with photoactivation of 
fluorescent CPP can be mitigated by replacing TMR-TAT with TMR conjugated to TAT 
by a disulfide bond (TMR-SS-TAT).  We have previously shown that biomolecules 
delivered into the cytosol will be cleaved at any exposed disulfide bond (2).  This break 
is caused by interaction with free glutathione (25), a cytosolic tripeptide composed of 
glycine, cysteine, and glutamic acid and involved in protein function and degradation of 
xenobiotics (e.g. drugs) (26).  Assumedly, after endosomal release, glutathione will 
cleave TMR-SS-TAT into nontoxic TMR and TAT, preventing localization of activated 
TMR to the plasma membrane and preventing lysis.  This hypothesis is based on our 
current model of TMR-TAT-induced cell death (22), and using TMR-SS-TAT should 
allow equivalent delivery with less chance of initiating apoptosis. 
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CHAPTER II 
METHODS 
 
Reagents 
Synthesis of TMR-TAT 
TAT peptide was synthesized by Fmoc solid-phase peptide synthesis using a rink amide 
MBHA resin substrate as described previously (2).  In short, Fmoc protected N-terminus 
amino acids were activated by HBTU, added to the resin, and deprotected by piperidine.  
The process was repeated until the TAT peptide (sequence: GRKKRRQRRRG) was 
completed.  TAMRA (5- (and 6-) carboxytetramethylrhodamine) was added to the N-
terminus of the peptide, forming TMR-TAT.  Product was removed from the resin by 
TFA and purified by HPLC.   
 
Fmoc (D)-amino acids and TMR were purchased from Novabiochem, and all other 
chemical reagents were purchased from Sigma-Aldrich. 
 
Synthesis of TMR-SS-TAT 
TAMRA ligated to pyridyldithio-ethylamine via the 5,6 carboxylic acid group was given 
to us by the lab of Jongdoo Lim.  Cysteine-TAT (sequence:  CGRKKRRQRRRG) was 
synthesized by solid phase peptide synthesis as described above.  Cys-TAT was reacted 
with the disulfide-activated TMR in Tris-Cl for 3 hours.  Product was purified by HPLC. 
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Synthesis of eGFP 
pTXB1-eGFP plasmid was transformed into BL21 E. coli bacteria (Thermo Fisher) and 
cultured in 6 liters LB medium (Thermo Fisher) at 37° C.  At mid-log growth phase 
(OD600 = 0.6), bacteria were induced with 0.5 mM IPTG (Thermo Fisher) and cultured 
for 4 hours at 37° C.  Cells were pelleted, resuspended in lysis buffer (20 mM Tris-Cl, 
200 mM NaCl), and sonicated (3000 Sonicator, Misonix Inc.).  After lysate fractionation 
by centrifuge (14,000 RPM for 40 min at 4° C), the soluble fraction was added to chitin 
beads (New England Biolabs) in lysis buffer and incubated at 4° C for 24 hours.  
(Proteins bind to the beads via the C-terminal intein-chitin binding domain/CBD 
purification tag.) 
 
The bead mixture was washed several times in a column with lysis buffer to remove 
unbound proteins.  Beads were then incubated for 24 hours in cleavage buffer (100 mM 
HEPES, 200 mM NaCl, 100 mM MESNA) to induce cleavage of eGFP-intein CBD 
from the intein-CBD-bead complexes.  Free eGFP was collected by several cleavage 
buffer washes and purified through an ion exchange column.  Samples were 
concentrated by Centricon spin filtration (Millipore), confirmed by mass spectroscopy, 
and quantified by absorbance (ε488 nm = 55,000 M-1cm-1) (27). 
 
All chemical reagents were purchased from Sigma Aldrich. 
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Assay specifications 
Cell lines 
The HeLa cervical cancer cell line was used in all experiments.  Cells were cultured in 
DMEM with 10% FBS in a 10 cm dish kept in a 5% CO2 incubator at 37° C.  Cells were 
passaged every 2-3 days when above 80% confluency.  Passaging protocol included 
removal of media, washes with PBS, incubation with 0.5% trypsin, 4-10x dilution by 
with DMEM, and inoculation onto a second dish. 
 
DMEM, FBS, trypsin EDTA, and PBS were purchased from Thermo Fisher, and 
Corning dishes were purchased from Sigma Aldrich. 
 
Delivery specifications 
Cells were subcultured in an 8-well dish overnight until 60-80% confluency.  Media was 
removed, and cells were washed three times with either PBS or L-15 medium.  Medium 
containing 1-2 µM CPP and/or 10-20 µM eGFP either with or without 50 µM crocetin (a 
inhibitor of photosensitization) was added, and cells were incubated at 37° C in the dark 
for 1 hour.  Cells were washed three times again with PBS or L-15 and kept at 37° C in 
cysteine-free L-15 either with or without 5 µM SYTOX Blue DNA stain for 
visualization and light treatment. 
 
8-well dishes were purchased from Thermo Fisher, crocetin was purchased from Sigma 
Aldrich, and Leibovitz L-15 and SYTOX Blue were purchased from Invitrogen. 
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Microinjection 
HeLa cells were plated on 35 mm plates (P35G-1.5-7-C-grid, MatTek Corp.) at 
~100,000 cells/mL in 2 mL DMEM and later washed and incubated with L-15.  10 µM 
TMR-TAT was mixed with 10 µM 70 kDa Dextran-fluorescein, and femtoliter aliquots 
were directly injected into the cytoplasm of live HeLa cells using a FemtoJet 
microinjector controlled by an InjectMan NI2 micromanipulator (Eppendorf).  
Microinjected cells were imaged/photoactivated, and cytosolic microinjection was 
confirmed by observing nuclear exclusion of 70 kDa Dextran.  
 
Fluorescent microscopy 
Cells were observed with a fluorescence inverted microscope with a spinning disk for 
confocal and wide-field visualization (microscope model: IX81 from Olympus).  The 
microscope was mounted with a 37° C stage for cell incubation and fitted with a back-
illuminated EMCCD chip camera (model: Rolera-MGI Plus from Qimaging) for 
imaging.  Samples were visualized by bright field imaging and with fluorescent light 
from a 100 W halogen lamp with RFP (λex = 560±20 nm; λem = 630±35 nm), FITC (λex = 
482±35 nm; λem = 536±40 nm), and CFP (λex = 436±20 nm; λem = 480±40 nm) standard 
fluorescent filter sets.  The RFP filter was used for photoactivation of fluorescent CPP 
and was controlled manually by varying neutral density filters (100%, 25%, 12.5%, or 
5% transmittance) and exposure time. Olympus SlideBook 4.2 software was used for 
fluorescence intensity quantification and image modulation (e.g. deconvolution, contrast 
modification, etc.). 
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CHAPTER III 
RESULTS 
 
 
We performed several trials of cargo/CPP coincubation in HeLa cells with the goal of 
endosomal release and cargo delivery.  TMR-TAT or TMR-SS-TAT served as CPPs 
with eGFP as cargo.  After incubation and washing, cells were visualized by confocal 
microscopy and photoactivated by the RFP fluorescence filter.  To date, no trials have 
shown effective/quantifiable delivery of cargo eGFP.  It is important to note that these 
are only preliminary results, and few trials were sufficiently repeated.  But if our trial 
results are reliable, trends and general phenomena inhibiting delivery can be observed in 
these preliminary trials. 
 
Cargo and CPP show endosomal localization but inefficient delivery  
CPP and cargo visualization with respective fluorescent filters (RFP and FITC) showed 
punctate (spotted) distribution, indicating endosomal localization of both fluorophores.  
Figure 1 shows standard images of each.  It was difficult to view cells with both filters 
in one image due to major differences in measured intensities of green and red 
fluorescence.  Visualization of green vesicles could only be accomplished with higher 
fluorescent intensities (100-50% transmittance).  Under these conditions, red 
fluorescence was too intense and was quickly photobleached (lost fluorescence due to 
fluorophore decay).  This disparity in observed intensities is partly a result of differences 
in UV light source intensities between the two filters.  Even so, because fluorescent 
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intensities of visible endosomes measured only slightly above background levels, both 
CPP and cargo displayed low endosomal uptake. 
 
After we confirmed evidence of punctated endosomal fluorescence, we attempted to 
induce endosomolysis by fluorescent CPP photoacceleration using RFP filter light pulses 
at various intensities and exposure times.  Successful delivery was defined by loss of 
punctate distribution coupled with increasing diffused (cytosolic) fluorescence at most 
points outside the nucleus.  Using these criteria as standards, we were unable to induce 
any discernable release of cargo or CPP into the cytosol.  Most trials were unsuccessful 
due solely to the inability to visualize cells properly—reagent-dish interactions and 
cellular debris (described later) often inhibited proper contrast between background and 
endosomal fluorescence.  For the few trials that produced qualifiable images, fluorescent 
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distribution remained punctate, accompanied with red and green photobleaching and cell 
death.  TMR-TAT and TMR-SS-TAT showed no difference in fluorescence or 
functionality. 
 
TMR-TAT photoactivation results in cell death even without significant endosomal 
release 
CPP coincubated with cargo failed to induce CPP release, contradicting previously 
observed results from PDT experiments that used TMR-TAT to induce apoptosis (22).  
This may be due to CPP-cargo interactions that inhibit proper endosomolysis.  Even 
cells incubated for 15 minutes with only eGFP and visualized with FITC showed 
noticeable death rates (data not shown), so the effect may be cumulative.  We incubated 
cells with TMR-TAT alone to attempt to reproduce previous results from our PDT trials.  
Interestingly, we could not induce detectable release of TMR-TAT into the cytosol but 
still observed consistent cell death after every pulse.  Figure 2 shows the results of one 
pulse trial, and Supplementary Video 1 shows time-lapse imaging of a continuous RFP 
pulse with no visible endosomal release.  It is possible that endosomal release was 
occurring at a low level but was masked by photobleaching and loss of overall 
fluorescence.  Furthermore, it should be noted that this was only one trial and may be 
anomalous.  We plan to replicate the conditions to confirm our preliminary findings. 
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Photoactivated TMR-TAT microinjected directly into cells does not induce death 
To determine if activated TMR-TAT that had escaped endosomes, even at undetectable 
levels, is responsible for cell death, we microinjected TMR-TAT directly into HeLa cells 
and treated with light under various conditions.  We hypothesized that TAT should 
localize to the inner face of the cytosolic membrane and, upon photoactivation, lyse the 
membrane, analogous to the proposed mechanism of cell death from TMR-TAT 
endosomolysis (22).  All trials except one showed no cell death despite several minutes 
of RFP exposure.  Cells visibly took up TMR-TAT and displayed significant 
fluorescence but showed no noticeable change in morphology, nuclear structure, or outer 
membrane stability (standard indicators of cell death).  Supplementary Video 2 shows a 
representative time-lapse of single trial. 
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The disulfide bond of TMR-SS-TAT does not prevent cell death 
To decrease the cytoxicity of TMR-TAT, we ligated TMR to TAT via a disulfide bond.  
This bond should be reduced by glutathione in the cytosol after endosomal escape, 
which prevent TAT from localizing TMR to the membrane (25).  After we coincubated 
and washed cells, we added SYTOX Blue, a dye that stains the nucleus upon cell death.  
We examined cells using the CFP fluorescent filter before and after an RFP pulse at 
various intensities and exposure times.  Preliminary tests show that the disulfide bond 
does not reduce cytoxicity, and most treated cells died after the pulse.  Even when cells 
were incubated and photoactivated in the presence of crocetin, a singlet oxygen inhibitor 
that we previously showed inhibited TMR-TAT-induced cell death (22), apoptosis still 
occurred.  Figure 3 shows an example trial with a 2.5 min pulse at the lowest intensity 
(5%).  We are currently undergoing cell viability trials testing only TMR-SS-TAT 
without cargo to better quantify our initial findings. 
  17 
 
 
Reagent incubation results in cell death and cellular debris 
As we prepared each experiment, we observed general cell morphology and confluency 
before and after each wash and incubation.  First wash triplicates reduced cell 
confluency, usually by 10%-20%.  We also observed significant dark toxicity (cell death 
without photoactivation) when cells were incubated with a CPP—after the second set of 
washes, confluency was reduced to 10%-20%, and we observed several patches of dead 
cells (Figure 4).  The cause of this toxicity without photosensitization is unknown.   
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Furthermore, as cells continued to die, cellular debris began to accumulate and float 
throughout the dish.  These clusters seemed to be stained by eGFP cargo and were 
highly fluorescent when viewed under the FITC filter (Figure 5).  This high 
fluorescence inhibited proper visualization of less fluorescent cargo in the endosomes 
and prevented delivery verification for many trials.  Most debris appeared after the 
second set of washes, possibly associating with eGFP during the 1 hour incubation, and 
continued to increase during visualization.  Therefore, this debris seems to be a direct 
result of cell apoptosis and fragmentation.   
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Both fluorescent CPPs stick to dish surface 
 Throughout all trials, we observed significant background fluorescence from the dish 
itself.  Upon observation, we noticed a speckled pattern that seemed to be a result from 
fluorescent CPP (either TMR-TAT or TMR-SS-TAT) sticking to the surface of the well.  
We confirmed that this signal was a result of incubation with CPP by comparison with 
background signal from an untreated dish (Figure A.1).  The speckled background 
fluorescence was not overwhelmingly high but still interfered with endosomal 
visualization by lowering the contrast ratio (Figure 6).  Because endosomal fluorescence 
was low, this effectively prevented confirmation of release for several trials.  
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Furthermore, it is possible that residual CPP on the dish surface could interact with 
different cellular processes and structures in the HeLa cells themselves. 
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CHAPTER IV 
ANALYSIS OF FINDINGS 
 
While our initial trials were unsuccessful, we were able to observe and characterize 
several issues that directly or indirectly inhibit proper delivery of eGFP.  Low 
endosomal concentration and release, CPP-dish adherence, and abnormally high cell 
death rates posed the biggest obstacles to successful trials. 
 
Possible causes of low endosomal uptake/release 
Even for the trials that we could visualize properly (no/low cellular debris, etc.), we still 
were unable to detect delivery of TMR-TAT/TMR-SS-TAT or eGFP and saw low 
endosomal uptake and low release.  These two processes of delivery are directly 
related—low uptake levels lead to low release.  It is reasonable to assume that some 
threshold level of activated TMR positioned near the endosomal membrane by TAT is 
required for proper 1O2 production and membrane lysis/leakage.  If fluorescent CPP 
concentrated in the endosome is unable to surpass this microenvironment threshold, 
release may not occur at a detectable level. 
 
Low uptake and release in trials with TMR-SS-TAT could possibly be due to 
spontaneous reduction and cleavage of the disulfide bond.  This would inhibit TAT-
mediated concentration of the fluorophore into the endosome and also prevent 
endosomolysis.  TAT could no longer localize TMR to the endosomal membrane, 
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rendering light treatment ineffective.  (We have previously shown that simple 
coincubation of unbound TMR and TAT fails to induce endosomolysis and death (22)).  
This disulfide cleavage may be a result of an external reducing agent in the media (e.g. 
cysteine) or a cellular metabolite, either secreted or endosomal. 
 
For both fluorescent CPPs, low uptake levels could be a result of cargo interference that 
impairs TAT interaction with cell surface heparin sulfate proteoglycans to induce proper 
macropinocytosis.  Similar or different interactions could occur in the endosome, 
preventing proper orientation of TMR for membrane lysis.  These interactions could be 
complex and may be a result of many different submolecular interactions.  Past 
experiments by others have shown that protein delivery is cargo-dependent to some 
extent (28). 
 
Because we could not induce endosomolysis when HeLa cells were incubated with 
TMR-TAT alone (Supplementary Video 1), CPP-cargo interactions cannot be the only 
factor inhibiting release.  Inability to release TMR-TAT from endosomes is a direct 
contradiction to previous trials which showed dispersal of TMR-TAT immediately 
before apoptosis (22).  This implies that the causes behind low TMR-TAT (and TMR-
SS-TAT) release may simply be due to use of inactive/damaged reagents.  We have 
noticed that synthesis/processing of our photosensitive reagents (TMR-TAT/TMR-SS-
TAT) under ambient light reduces functionality and fluorescence, presumably due to 
photobleaching.  Our TMR-TAT stock solution could have been inactivated by transport 
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during synthesis.  We have instituted new methods of peptide synthesis and now keep 
most reagents in a dark environment to preserve photoactivity.  Further trials with new 
stock solutions are needed to test this theory. 
 
Finally, this inability to induce release in the PDT replication experiment (incubation 
with TMR-TAT alone) could have been anomalous.  We were only able to perform one 
set of trials, and any number to environmental factors (sick cells, bad media, etc) could 
have conceivably interfered with proper delivery.  Surprisingly, we were able to induce 
apoptosis with all pulses (Figure 2), indicating that some biomolecular cell process 
catalyzed by light treatment was occurring.  Repeats of TMR-TAT controls are needed 
to further support these initial findings.  
 
Effects of fluorescent CPP-dish interaction 
TMR-TAT/TMR-SS-TAT adherence to the dish is not an entirely new phenomenon—
we have witnessed some degree of dish surface adherence in previous trials with many 
reagents.  Some basal level of reagent loss always occurs, mostly at negligible quantities.  
But because uptake was low, the contrast between intra- and extracellular fluorescence is 
less, lowering the reliability of imaging (Figure 6).  Furthermore, activated fluorescent 
CPP adhering to the dish may explain some cell death seen in all trials (explained 
below). 
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It is unknown whether the CPP is adhering directly to the dish or to some biomolecular 
intermediate.  Elucidating these mechanisms could help to provide inhibitory methods to 
reduce this adherence. 
 
Possible causes of cell death 
Both TMR-TAT and TMR-SS-TAT displayed dark and light cytotoxicity (during 
incubation and visualization).  We have often observed some degree of dark toxicity 
during incubation with other potential reactive reagents, including TAT-E5 (16). 
Normally, death during incubation is negligible and should be considered an 
unavoidable aspect of cell delivery.  It is unexpected that our estimated death rates were 
so high (up to 60% confluency loss to death – Figure 4), even when incubated with 
normally innocuous eGFP.  The cause of this toxicity is unknown, but such high rates 
may be cause for investigation.   
 
We previously postulated that the cell death seen from TMR-TAT activation is due to 
reactive TMR escaping endosomes and disrupting the plasma membrane (22).  Our 
observations from current trials have pushed us to reconsider this hypothesis.  If cell 
death occurs primarily by loss of plasma membrane integrity, photoactivation of 
microinjected TMR-TAT should also induce cell death.  Our results show that 
microinjected cells are resistant to light toxicity (Supplementary Video 2), implying 
that TMR-TAT-directed membrane instability may only be a minor factor in the cell 
death observed in our trials.   
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Other factors that drive cell death undoubtedly contribute, as evidenced by induction of 
cell death without endosomal release (Supplementary Video 1).  In our previous model, 
TMR-TAT must diffuse through the cytosol to directly interact with the plasma 
membrane to cause death, which is impossible without endosomolysis.  Furthermore, 
TMR-SS-TAT showed light toxicity, even though the disulfide motif has been shown to 
be cleaved in the reducing cytosol (2).  Without this bond, TAT is incapable of 
localizing TMR to the cell membrane to induce lysis.  Other mechanisms must be 
operating to explain these results. 
 
It is possible that some undetectable release is occurring, allowing a small amount of 
TMR-TAT to escape and destroy the plasma membrane, requiring only a slight 
modification to our previous model.  If only a minute concentration of TMR-TAT is 
needed for death, this could explain light toxicity associated with TMR-SS-TAT (Figure 
3).  A small portion of the CPP could escape disulfide reduction and, if above a 
minimum threshold, could disrupt other membrane structures.  This modified model 
does not explain our microinjection results unless high intracellular concentrations of 
TMR-TAT are somehow inhibitory to cell death. 
 
 It is also possible that some TMR-produced reactive oxygen species, such as H2O2 or 
1O2, is able to diffuse to other areas of the cell and interfere with structural or metabolic 
functions.  This proposed mechanism is compatible with other models and with all of our 
own experiments, except microinjection.  Unfortunately, 1O2 has a very short lifetime 
  26 
(less than 1 µs), which impairs broad travel through the cell (18). 1O2 would have to be 
localized in some manner by TMR near a disruptable biochemical structure.  Finally, if 
non-1O2 ROS, such as H2O2, played a significant role in cell death, microinjected TMR-
TAT would induce apoptosis.  Because we could not produce this result, our previous 
model of death primarily by 1O2 is supported. 
 
Our inability to induce death from microinjection implicates that endosomal release is a 
integral step in fluorescent CPP-induced cell death.  Late endosomes and lysosomes 
contain potentially toxic biomolecules, such as ROS and non-specific proteases that are 
destructive to the cell if released.  Our dark incubation (1 hour) could allow unperturbed 
endosomal maturation, concentrating these toxic components in the endosome.  Light 
treatment could incite release of these degradative chemicals and proteins, causing 
catastrophic loss of cellular homeostasis.  No trials directly contradict this model, though 
apoptosis without endosomal release cannot be supported by this model alone.  Again, it 
is possible that undetectable release occurred or that some other mechanism was 
contributing. 
 
Finally, the cell membrane could be interacting with TMR-TAT adhering to the dish 
surface from incubation (Figure 6).  During light treatment, this layer could be 
activated, causing lysis of the plasma membrane directly.  This model is compatible with 
our previous experiments (22) and may show a cumulative effect with any other 
mechanism.  Unfortunately, if this were true, microinjection should also induce death.  It 
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is clear that photoinduced cell death is a complex and multifactorial phenomenon and 
requires further study. 
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CHAPTER V 
FUTURE PLANS 
 
 
Changes to current protocol 
Varying reagent concentration 
For our preliminary experiments, we used concentrations of CPP and cargo that have 
been optimized from previous tests (16,22).  The next and simplest step would be to vary 
these concentrations to favor delivery instead of PDT.  This includes decreasing the 
concentration of fluorescent CPP, which might reduce cell death and reagent adhesion to 
the dish.  We could also increase the concentration of cargo, which would increase 
signal but could potentially increase cytotoxicity. 
 
Crocetin in the medium during incubation and visualization did not prevent cell death 
(Figure 3).  But because our trials were qualitative only, it could still theoretically have 
other effects, such as slowing the apoptotic process.  Quantitative trials are needed, and 
increasing crocetin concentration could significantly reduce death.  Finally, if death 
occurs due to catastrophic release of endosomal contents, the surrounding medium may 
need to be modified to compensate for released cytotoxic components.  Possibilities 
include decreasing medium ion concentration and/or supplementation of protease or 
reactive oxygen species inhibitors. 
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Modifying the dish surfaces 
Because reagent-dish interactions limit visualization and may influence cell death, it is 
worthwhile to limit residual TMR-TAT after washes.  This can be accomplished by 
altering the reactivity of the dish surface by chemical or physical means.  The simplest 
method is coating the dish with a reactive chemical substrate such as polylysine.  In 
theory, the positive charges of lysine could repel highly cationic TAT, preventing 
adhesion.  Furthermore, dishes coated with polylysine show higher cell adhesion (29), 
which may reduce loss of cells due to the mechanical stress of washing.   
 
Varying exposure time and intensity 
Photochemical internalization offers an advantage over other delivery methods by 
allowing manual control over the duration of endosomolysis by manipulating light 
treatment.  While we have varied the intensity and time of our RFP pulse, we have not 
been able to prevent cell death.  Therefore, fine-tuning the RFP pulse would probably 
optimize delivery once other aspects are under control but is not a determining factor of 
cell death.  For example, if we can initiate predictable endosomal release, our next steps 
would be to quantify the duration of this release and correlate this duration to pulse 
parameters.  Finally, once we limit cell death by changing other aspects of our protocol, 
we can relate pulse parameters to cell death rates to determine best conditions to balance 
delivery with death. 
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Using different reagents 
While TMR may be useful as a low 1O2-producing agent for PDT, it could be too 
cytotoxic for delivery at any concentration.  We are currently investigating other agents 
that produce singlet oxygen or other reactive oxygen species.  These new reagents may 
be more endosomolytic but less cytotoxic, or they may be less reactive to light, allowing 
finer control over release.  Previous trials have proven that protein delivery efficiency is 
highly dependent on the cargo itself.  Therefore, using a different cargo could more 
compatible with our TMR-TAT delivery protocol.  Fluorescent dextrans may be ideal 
candidates due to nonreactivity and variability in size.  We could also provide buffer-like 
components to balance out any undesired cargo side reactions.  These could include 
emulsifiers to coat the cargo or counterions to neutralize charges.  Though our initial 
tests showed that crocetin was unable to prevent eventual cell death, other oxygen 
scavengers could be better suited for our trials.  Systematically using chemical inhibitors 
with different biochemical targets could also help to elucidate the mechanisms driving 
cell death. 
 
Using different assays for delivery 
So far, we have only used fluorescence as verification of delivery due to ease of use and 
ability to study delivery in real time.  But recent problems inherent with our fluorescent 
trials (e.g. TMR-TAT adherence to dish, fluorescent cellular debris) prove that other 
assay methods need to be considered.  Methods to assay functionality of a translocated 
biomolecule can also be utilized to determine delivery efficacy.  For instance, 
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transducing mitogens (cell mitosis stimulants) and quantifying cell population, 
transducing transcription factors and quantifying expression, or transducing growth 
signals and quantifying cell differentiation are all possibilities.  Such trials could also 
support the use of our TMR-TAT delivery method for modification of complex cellular 
processes or even for in vivo applications. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
 
In summary, though preliminary trials have been unsuccessful, we have been able to 
identify and study several obstacles that inhibit proper delivery.  We show that 
inefficient uptake and release, reagent/dish interactions, and cell death all interact to 
prevent proper confirmation of delivery.  We have been able to outline several 
modifications to our protocol to enhance the probability of success.  Such modifications 
are minor, and we believe that delivery is still likely.  If our trials are successful, we 
believe our TMR-TAT delivery method could have significant applications in a broad 
range of areas. 
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APPENDIX I	  
TECHNICAL ACRONYMNS	  
CFP Cyan fluorescent protein 
DMEM Dulbecco's modified eagle medium 
FBS Fetal bovine serum 
FITC Fluorescein isothiocyanate 
HBTU 2-(1H-benzotriazol-1-yl)-1,1,3,3,-tetramethyluronium 
 hexafluorophosphate 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPLC High performance liquid chromatography 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
MBHA Methylbenzhydrylamine Hydrochloride 
MESNA Sodium 2-sulfanylethanesulfonate 
RFP Red fluorescent protein 
TAMRA 5 (and 6) – Carboxytetramethylrhodamine 
Tris-Cl Tris(hydroxymethyl)amino methane  
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APPENDIX II	  
ADDITIONAL FIGURE	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